Grower Orders Agrarius for 384,000 Citrus Trees

A Brazilian citrus grower placed its first commercial order for the Agrarius application after independent trials reported yield gains.

Updated on Nov. 17, 2026 in Agriculture

Screen-print poster illustration of a single citrus tree with green and yellow fruit in a receding grove under warm light.
Brazilian citrus grower places first commercial order for Agrarius after Farmatac trials show yield gains in HLB-affected orchard. AI Illustration. Upload story photo >

A Brazilian citrus grower has placed an initial commercial order for The More Life Company Corp.'s Agrarius application, covering approximately 384,000 trees. The decision followed second-cycle assessments by independent agricultural research partner Farmatac, which recorded yield increases in the grower's main harvest.

Why it matters

The order signals commercial interest in Agrarius in citrus orchards affected by Huanglongbing (HLB), or citrus greening, a disease that has challenged growers across Latin America. The company says it does not claim Agrarius treats or cures HLB, so the results describe yield effects rather than disease elimination.

Farmatac estimated a 62.7 per cent increase in concentrated-juice output, from about 2.5 to 4.1 tons per hectare, compared with standard management in the trial orchard. These are estimates from the assessment, and the full methodology and long-term orchard effects remain unreported.

The players

The More Life Company Corp.

The More Life Company Corp. is the developer and commercial promoter of the Agrarius application, which it markets to agricultural producers.

Farmatac

Farmatac is an independent agricultural research partner that conducted the Agrarius yield assessments in the grower's orchard.

The details

Farmatac conducted assessments in an HLB-affected orchard, comparing Agrarius-treated areas with standard management areas across the grower's operation. Results from the first evaluation cycle, announced December 1, 2025, were followed by second-cycle pre-harvest assessments that informed the grower's commercial decision.

Timeline

  1. December 1, 2025: Farmatac announces first evaluation cycle results.

  2. 2026: Grower's main-harvest yields are recorded in treated and standard areas.

  3. November 17, 2026: Grower places initial commercial order for 384,000 trees.

Industry Context

Citrus greening has been a persistent threat to Brazil's orange sector, pressuring yields and pushing growers to seek management tools that work alongside existing orchard practices. The Agrarius order reflects that search for yield-focused options rather than a disease cure.

Growers managing HLB-affected groves can weigh whether application-based yield trials justify expanding treated acreage in their own orchards. Producers evaluating similar tools should compare their own yield records against standard management before committing to large orders.

The takeaway

Yield-focused trial results can guide commercial decisions, but single-orchard estimates should be checked against your own records before scaling up. Growers facing citrus greening should treat application tools as yield support rather than disease cures.

Further reading

Explore more agriculture coverage on how growers are managing crop disease and yield pressure.

Source note: This article includes information reported by Freshplaza.